Search:   [Advanced]

Search Results

Search for "Metoprolol" returned 39 results

previous12next

Showing 1-20 out of 39

DrugBank ID	Name	Formula	Weight
DB00264	Metoprolol	C15H25NO3	267.3639
	Metoprolol Metoprolol, a competitive, beta1-selective (cardioselective) adrenergic antagonist, is similar to atenolol in its moderate lipid solubility, lack of intrinsic sympathomimetic activity ...
DB00335	Atenolol	C14H22N2O3	266.3361
	... 3-(propan-2-ylamino)propoxy]phenyl]acetamide D00235 Like metoprolol, atenolol competes with sympathomimetic neurotransmitters such as catecholamines for binding at beta(1)-adrenergic receptors ...
DB00571	Propranolol	C16H21NO2	259.3434
	... yloxy-3-(propan-2-ylamino)propan-2-ol C07407 Like atenolol and metoprolol, propranolol competes with sympathomimetic neurotransmitters such as catecholamines for binding at beta(1)-adrenergic ...
DB00236	Pipobroman	C10H16Br2N2O2	356.0540
	... Carvedilol Antagonism Esmolol Antagonism Labetalol Antagonism Metoprolol Antagonism Nadolol Antagonism Oxprenolol Antagonism Penbutolol Antagonism Pindolol Antagonism Practolol Antagonism ...
DB00983	Formoterol	C19H24N2O4	344.4049
	... Carvedilol Antagonism Esmolol Antagonism Labetalol Antagonism Metoprolol Antagonism Nadolol Antagonism Oxprenolol Antagonism Penbutolol Antagonism Pindolol Antagonism Practolol Antagonism ...
DB01288	Fenoterol	C17H21NO4	303.3529
	... of arterial pressure Methyldopa Increased arterial pressure Metoprolol Antagonism Midodrine Increased arterial pressure Moclobemide Moclobemide increases the sympathomimetic effect Nadolol ...
DB00816	Orciprenaline	C11H17NO3	211.2576
	... of arterial pressure Methyldopa Increased arterial pressure Metoprolol Antagonism Midodrine Increased arterial pressure Moclobemide Moclobemide increases the sympathomimetic effect Nadolol ...
DB00871	Terbutaline	C12H19NO3	225.2842
	... of arterial pressure Methyldopa Increased arterial pressure Metoprolol Antagonism Midodrine Increased arterial pressure Moclobemide Moclobemide increases the sympathomimetic effect Nadolol ...
DB00554	Piroxicam	C15H13N3O4S	331.3460
	... The NSAID increases the effect and toxicity of methotrexate Metoprolol Risk of inhibition of renal prostaglandins Nadolol Risk of inhibition of renal prostaglandins Oxprenolol Risk of ...
DB00247	Methysergide	C21H27N3O2	353.4580
	... with this combination Labetalol Ischemia with risk of gangrene Metoprolol Ischemia with risk of gangrene Nadolol Ischemia with risk of gangrene Naratriptan Possible severe and prolonged ...
DB00343	Diltiazem	C22H26N2O4S	414.5180
	... Mesoridazine Increased risk of cardiotoxicity and arrhythmias Metoprolol Increased risk of bradycardia Midazolam The calcium channel blocker increases the effect and toxicity of the ...
DB00457	Prazosin	C19H21N5O4	383.4011
	... Labetalol Risk of hypotension at the beginning of therapy Metoprolol Risk of hypotension at the beginning of therapy Nadolol Risk of hypotension at the beginning of therapy Oxprenolol Risk of ...
DB00575	Clonidine	C9H9Cl2N3	230.0940
	... Labetalol Increased hypertension when clonidine stopped Metoprolol Increased hypertension when clonidine stopped Mirtazapine Possible hypertensive crisis Nadolol Increased hypertension when ...
DB01050	Ibuprofen	C13H18O2	206.2808
	... The NSAID increases the effect and toxicity of methotrexate Metoprolol Risk of inhibition of renal prostaglandins Nadolol Risk of inhibition of renal prostaglandins Oxprenolol Risk of ...
DB01175	Escitalopram	C20H21FN2O	324.3919
	... Combination associated with possible serotoninergic syndrome Metoprolol The SSRI increases the effect of the beta-blocker Naratriptan Increased risk of CNS adverse effects Oxycodone Increased ...
DB00215	Citalopram	C20H21FN2O	324.3919
	... Combination associated with possible serotoninergic syndrome Metoprolol The SSRI increases the effect of the beta-blocker Moclobemide Possible serotoninergic syndrome Naratriptan Increased ...
DB01182	Propafenone	C21H27NO3	341.4440
	... Mesoridazine Increased risk of cardiotoxicity and arrhytmias Metoprolol Propafenone increases the effect of the beta-blocker Mexiletine Propafenone increases the effect and toxicity of ...
DB00280	Disopyramide	C21H29N3O	339.4745
	... Mesoridazine Increased risk of cardiotoxicity and arrhythmias Metoprolol The beta-blocker increases toxicity of disopyramide Moxifloxacin Increased risk of cardiotoxicity and arrhythmias ...
DB00328	Indomethacin	C19H16ClNO4	357.7880
	... The NSAID increases the effect and toxicity of methotrexate Metoprolol Risk of inhibition of renal prostaglandins Nadolol Risk of inhibition of renal prostaglandins Oxprenolol Risk of ...
DB00414	Acetohexamide	C15H20N2O4S	324.3950
	... The beta-blocker decreases the symptoms of hypoglycemia Metoprolol The beta-blocker decreases the symptoms of hypoglycemia Nadolol The beta-blocker decreases the symptoms of hypoglycemia ...

Showing 1-20 out of 39

previous12next

This project is supported by Genome Alberta & Genome Canada, a not-for-profit organization that is leading Canada's national genomics strategy with $600 million in funding from the federal government. This project is also supported in part by GenomeQuest, Inc., an enterprise genomic information company serving the life science community.